{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:03:22Z","timestamp":1784217802746,"version":"3.55.0"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T00:00:00Z","timestamp":1415750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32 CA 108456"],"award-info":[{"award-number":["5T32 CA 108456"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001320","name":"Roswell Park Cancer Institute","doi-asserted-by":"publisher","award":["NCI P30 CA 016056"],"award-info":[{"award-number":["NCI P30 CA 016056"]}],"id":[{"id":"10.13039\/100001320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.gore.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T17:48:17Z","timestamp":1416246497000},"page":"10-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator"],"prefix":"10.1016","volume":"11","author":[{"given":"Kassondra S.","family":"Grzankowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Brightwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kasznica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunle O.","family":"Odusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2014.11.002_bb0005","series-title":"SEER Cancer Statistics Review","author":"Howlader","year":"1975"},{"issue":"2","key":"10.1016\/j.gore.2014.11.002_bb0010","first-page":"32","article-title":"Peritoneal mesothelioma: a review","volume":"9","author":"Bridda","year":"2007","journal-title":"MedGenMed"},{"issue":"11","key":"10.1016\/j.gore.2014.11.002_bb0015","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.humpath.2005.08.008","article-title":"Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas","volume":"36","author":"Ord\u00f3\u00f1ez","year":"2005","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.gore.2014.11.002_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.pap.0000201832.15591.1d","article-title":"Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update","volume":"13","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Adv. Anat. Pathol."},{"issue":"14","key":"10.1016\/j.gore.2014.11.002_bb0025","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.gore.2014.11.002_bb0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cam4.80","article-title":"A contemporary analysis of morbidity and outcomes in cytoreductive\/hyperthermic intraperitoneal chemoperfusion","volume":"2","author":"Haslinger","year":"2013","journal-title":"Cancer Med."},{"issue":"36","key":"10.1016\/j.gore.2014.11.002_bb0035","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.gore.2014.11.002_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","article-title":"Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program","volume":"7","author":"Janne","year":"2005","journal-title":"Clin. Lung Cancer"}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578914000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578914000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:53:32Z","timestamp":1762480412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578914000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":8,"alternative-id":["S2352578914000423"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2014.11.002","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc","name":"copyright","label":"Copyright"}]}}